medigraphic.com
SPANISH

Salud Mental

ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 5

<< Back

Salud Mental 2007; 30 (5)

Uso de alcohol, tabaco y drogas en población mexicana, un estudio de cohortes

Fleiz C, Borges G, Rojas E, Benjet C, Medina-Mora ME
Full text How to cite this article

Language: Spanish
References: 49
Page: 63-73
PDF size: 91.07 Kb.


Key words:

Substance use, cohorts, socio-demographic correlates.

ABSTRACT

Introduction
The availability of drugs and its impact upon our society is undeniably a public concern; the question that remains is to what extent is the population affected. Different sources of information suggest that drug use in Mexico is increasing, especially among the adolescent population. As it has been thirty years since the first epidemiological study of drug use was conducted in Mexico in the 1970´s, this is an opportune moment to evaluate the problem by age cohort. This research addresses the question of whether changes in substance use have differentially affected the younger population in terms of the evolution of ages of onset and the sociodemographic determinants of lifetime consumption.
Method
This study is a part of the World Mental Health Surveys Initiative from the WHO which was undertaken simultaneously in 30 countries. The target population was taken from uninstitutionalized persons with a fixed residence, between 18 and 65 years of age, and living in urban areas (as defined by more than 2500 inhabitants). The survey is based on a probabilistic, multistage design, stratified by six geographic areas at the national level. Eligible respondents were defined as persons, aged 18 to 65 at the time of the survey, who normally eat, sleep and prepare meals in the household and limited to those that speak Spanish. A total of 5826 individuals were interviewed with a weighted individual response rate of 76.6%. The computer assisted version of the World Mental Health Composite International Diagnostic Interview (WMH-CIDI)was administered. The interview length varied from a minimum of 20 minutes to a maximum of nine hours in four sessions. Fieldwork was carried out by 34 lay interviewers with prior experience in survey data collection and trained by professionals certified by the WHO in the use and training of the CIDI. Standard errors of the estimated prevalences were calculated by the Taylor linearization method using the SUDAAN 2002 statistical package. Kaplan Meir survival curves were generated for the ages of onset using the SAS 2001 software. Logistic regressions were performed to study the demographic correlates of substance use. Estimates of standard errors of odds ratio (ORs) from logistic regression coefficients were also obtained by SUDAAN, and 95% Confidence Intervals (CI) have been adjusted to design effects.
Results
Alcohol is the most used substance with less variation by age; 86% of those interviewed report alcohol consumption at some time in their life. The prevalence of alcohol use is followed by tobacco use. Sixty percent of the population report having used tobacco, reaching the greatest proportion of the population in the 45 to 54 year old age group (63%). The non-medical use of drugs, including illicit drugs and legal drugs without a medical prescription, reaches 10% of the population. The illegal use of drugs, including the nonmedical use of legal drugs and illicit drugs, in particular marijuana and cocaine, is more frequent among the young and prevalence diminishes with age. Beginning in adolescence, there is a growing prevalence of those reporting the use of these substances, stabilizing shortly before the age of 30. A discrete time survival analysis to estimate the variation in the lifetime prevalence by cohort showed variations in drug use by cohort for all the substances studied, even for alcohol consumption. In all cases, compared to the oldest cohort, the younger cohort are at greater risk of substance use and the greatest risks are concentrated always in the youngest cohort. The cohort differences in probability of substance use is greatest for cocaine, with increases of up to 100 times the risk for those between 18 and 29 years of age. Results of a logistic regression model demonstrate that age continues to be an important risk factor for non-prescription medical substance use, marijuana and cocaine, but not for alcohol and tobacco. For all substances, use is substantially lower for females as well as for the homemaker category of employment. There are no consistent differences for the other demographic variables across the five types of substances.
Discussion
This report documents an increase in the risk for substance abuse problems among today’s youth, greater than the risk faced by their parents or grandparents at the same age. Use begins increasing during adolescence and stabilizes shortly before the age of 30. There are variations by type of drug such that marijuana has maintained an early age of onset in the different age cohorts while for the use of other substances new cases of onset are found after this age; the substance that shows the greatest proportion of new onset at later ages is cocaine. Even so, the risk of cocaine use is considerably greater in younger cohorts. Survival analysis confirms that compared to older cohorts, the younger have greater risk of substance use and these risks are particularly striking for cocaine use, with as much as 100 times the risk for those between 18 and 29 years of age. These findings coincide with those reported in previous studies in that alcohol and tobacco use surpass by far the use of other substances, with greater use of alcohol than tobacco and both above any other substance. The rate of tobacco and alcohol use is similar throughout the lifespan signifying that this is an endemic problem in our country. On the other hand, findings regarding the use of illegal drugs, in particular marijuana and cocaine, and non-prescription medical drugs show a preponderance of use in the young. These findings reflect the tendencies already reported in other studies. Marijuana use is not new, and has a long tradition throughout the country for which it is not surprising that these results show cases of consumption in all age groups and that the age of onset is similar in all age cohorts, around 17 years of age. However, the growth of marijuana use is reflected by greater lifetime prevalence in the young, three times greater among those now currently 18 to 29 years of age than those of the same age in the 1970´s. The use of cocaine before that decade was limited to isolated groups as a socially sophisticated diversion; there is a resurgence in the 1990´s when an important increase in use is reflected in all the available surveillance systems. This is reflected in our results by the lower exposure to this drug in the older cohorts. While the risk of marijuana use is 16 times lower in the older cohort than the younger, the risk of cocaine use is 100 times lower in the older cohort than the younger. Our findings suggest that age continues to be an important risk factor for the use of illegal drugs and medical drugs without a prescription, but not for alcohol or tobacco. For all substances, use is lower for females as well as for homemakers indicating that double standards between the genders are still applied. For alcohol there are slightly lower risks for those with lesser educational attainment. This is consistent with other studies which have documented that alcohol consumption increases with buying power which is in turn associated with increased education. These results suggest the need to undertake further research which would allow us a more in depth understanding of the role that social position, including marital status, plays in substance use and abuse.
Conclusions
These findings support the hypothesis that the younger generation of today has a greater risk of substance use when compared to their parents when they were young. This point out to the need of increasing actions aimed at reducing the negative impact of this phenomena upon health and society.


REFERENCES

  1. BERENZON S, MEDINA-MORA ME, CARREÑO S, JUAREZ F y cols.: Las tendencias del consumo de sustancias psicoactivas entre los estudiantes de enseñanza media y media superior del Distrito Federal, 1993. Salud Mental, 19(1):1-5, 1996.

  2. CARAVEO AJ, COLMENARES E, SALDIVAR G: Morbilidad psiquiátrica en la Ciudad de México: Prevalencia y comorbilidad durante la vida. Salud Mental (Número Especial):22:62-67, 1999.

  3. CASTRO ME, ROJAS E, GARCIA G, DE LA SERNA J: Epidemiología del uso de drogas en la población estudiantil. Tendencias en los últimos 10 años. Salud Mental, 9(4):80-85, 1986.

  4. DE LA FUENTE R, PUCHEU C, CAMPILLO C: El problema de la farmaco-dependencia. Salud Pública Méx, 14(2):169-190,1972.

  5. DE LA SERNA J, ROJAS E, ESTRADA MA, MEDINAMORA ME: Medición del uso de drogas en estudiantes de educación media y media superior del Distrito Federal y zona conurbada, 1989. Anales. Reseña de la VI Reunión de Investigación. Instituto Mexicano de Psiquiatría, México, 183- 187, 1991.

  6. DEMYTTENAERE K, BRUFFAERTS R, POSADA-VILLA J y cols.: World Mental Health Survey Consortium. Prevalence, severity and unmet need for treatment of mental Disorders in the world health organization. World Mental Health Surveys. JAMA, 291:2581-2590, 2004.

  7. DIAZ JL: Ethnopharmacology of sacred psychoactive plants used by the indians of Mexico. J Pharmacol Toxicol, 17:647- 675, 1977.

  8. FRENK J, RUELAS E, BOBADILLA J, ZURITA B y cols.: Economía y Salud: Propuesta para el Avance del Sistema de Salud en México. Informe Final. Fundación Mexicana para la Salud. México, 1999.

  9. GUISA-CRUZ VM, SANCHEZ-HUESCA R, DIAZNEGRETE DA, CASTILLO-FRANCO I y cols.: Consumo de drogas entre pacientes de primer ingreso a tratamiento en Centros de Integración Juvenil en 2002. En: Observatorio Mexicano en Tabaco, Alcohol y Otras Drogas 2003. CONADIC, SSA, 33-48, México, 2004.

  10. HOSMER DW, LEMESHOW S: Applied Logistic Regression. Segunda edición. John Wiley & Sons, Nueva York, 2000.

  11. INSTITUTO NACIONAL DE ESTADISTICA GEOGRAFIA E INFORMATICA (INEGI). Encuesta Nacional de Ingresos y Gastos, México, 1994.

  12. KESSLER RC, ÜSTÜN TB: The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Re, 13:93-121, 2004.

  13. MEDINA-MORA ME: Prevalencia del Consumo de Drogas en algunas Ciudades de la República Mexicana. Encuesta de Hogares. Rev Enseñanza Investigación Psicológica, 4(17):111-115, 1978.

  14. MEDINA-MORA ME: El consumo de alcohol en México y sus problemas asociados. Salud Mental, 10(4):81-91, 1987.

  15. MEDINA-MORA ME, BORGES G, FLEIZ C, BENJET C y cols.: Prevalence and correlates of drug use disorders in Mexico. Rev Panamericana Salud Pública, 19(4):265-276, 2006.

  16. MEDINA-MORA ME, BORGES G, LARA MC, BENJET C y cols.: Prevalencia de trastornos mentales y uso de servicios: resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Mental, 26(4):1-16, 2003.

  17. MEDINA-MORA ME, BORGES G, LARA C, BENJET C y cols.: Mexican National Comorbidity Survey (NCS-Mexico): An overview of Design and field procedures. World Health Organization’s (WHO) World Mental Health Surveys Initiative. WWW. hcp.med.harvard-edu/wmh/WMH%20Country%20Reportshtm

  18. MEDINA-MORA ME, BORGES G, VILLATORO J: The measurement of drinking patterns and consequences in Mexico. J Substance Abuse, 12:183-196, 2000.

  19. MEDINA-MORA ME, CRAVIOTO P, VILLATORO J, FLEIZ C y cols.: Consumo de drogas entre adolescentes: resultados de la Encuesta Nacional de Adicciones, 1998. Salud Pública Mex, 45(supl 1):16-25, 2003.

  20. MEDINA-MORA ME, NATERA G, BORGES G: Del siglo XX al tercer milenio. Las adicciones y la salud pública: drogas, alcohol y sociedad. Salud Mental, 24(4):3-19, 2001.

  21. MEDINA-MORA ME, NATERA G, BORGES G: Alcoholismo y abuso de bebidas alcohólicas. En: CONADIC, SPPS, INPRFM, CIJ, IMSS, SCT, ISSSTE, PEMEX (eds). Observatorio Mexicano en Tabaco, Alcohol y otras Drogas 2002. 15-25, CONADIC, México, 2002.

  22. MEDINA-MORA ME, ORTIZ A, RASCON ML, LOPEZ EK y cols.: Trends of drug use in Mexico City. Community Epidemiology Work Group. Epidemiologic Trends in Drug Use: Proceedings December 1990, NIDA, 337-347, Rockville, 1991.

  23. MEDINA-MORA ME, ROJAS E, GALVAN J, JUAREZ F y cols.: Drug use among mexican student youth. En: Johnson Bassin and Shaw (eds). Epidemiologic Trends in Drug Abuse. Community Epidemiology Work Group. 483-494, NIDA, Rockville, 1992.

  24. MEDINA-MORA ME, ROJAS E, JUAREZ F, BERENZON S y cols.: Consumo de sustancias con efectos psicotrópicos en la población estudiantil de enseñanza media y media superior de la República Mexicana. Salud Mental, 16(3):2-8, 1993.

  25. MEDINA-MORA ME, SEPULVEDA J, RASCON ML, LAZCANO F y cols.: Patrones de consumo de alcohol y síntomas de dependencia en una región del centro de la República Mexicana. Rev Lat Alcohol Drogas, 1(1):47-56, 1989.

  26. MEDINA-MORA ME, TAPIA CR, RASCON ML, SOLACHE G y cols.: Situación Epidemiológica del abuso de drogas en México. Bol Sanit Panam, 107(6):475-484, 1989.

  27. MEDINA-MORA ME, TAPIA R, SEPULVEDA J, OTERO R y cols.: Extensión del consumo de drogas en México. Encuesta Nacional de Adicciones. Resultados Nacionales. Salud Mental, 12(2:)7-12,1989.

  28. MEDINA-MORA ME, VILLATORO J, CRAVIOTO P, FLEIZ C y cols.: Uso y abuso de alcohol en México: Resultados de la Encuesta Nacional de Adicciones 2002. En: Observatorio Mexicano en Tabaco, Alcohol y otras Drogas 2003. CONADIC, SSA, 49-61, México, 2004.

  29. NATERA G: México. En: Heath D (ed). International Handbook on Alcohol and Culture. Greenwood Press, 179-189, Londres, 1995.

  30. OFFICE OF APPLIED STUDIES: SAMHSA National Household Survey on Drug Abuse. SAMHSA, Rockville, 2001.

  31. ORTIZ A, MARTINEZ R, MEZA D: Grupo Interinstitucional para el desarrollo del Sistema de Reporte de Información en Drogas. Resultados de la aplicación de la cédula: “Informe individual sobre consumo de drogas”. Tendencias en el área metropolitana No. 39, noviembre, 2005.

  32. ORTIZ A, SORIANO A, GALVAN J: Resultados Del Sistema de Reporte de Información en Drogas. En: Observatorio Mexicano en Tabaco, Alcohol y otras drogas 2003. CONADIC, SSA, 45-48, México, 2004.www.inprf.org.mx/sociales/s rid/ principal.htm/

  33. ORTIZ A, UNIKEL C, FLORES JC, SORIANO A y cols.: Trends of drug use in Mexico City from 1987 to 1995. The Information Reporting System on Drugs. En: NIDA (ed). Epidemiologic Trends in Drug Abuse. Community Epidemiology Work Group: December 1996. Volume II: Proceedings. NIDA, 380-392, Rockville, 1997.

  34. SAS INSTITUTE I: SAS/STAT Software: Changes and Enhancements, Release 8.2. SAS Publishing; Cary, 2001.

  35. SECRETARIA DE SALUD, DIRECCION GENERAL DE EPIDEMIOLOGIA, INSTITUTO MEXICANO DE PSIQUIATRIA: Primera Encuesta Nacional de Adicciones. México, 1988..

  36. SECRETARIA DE SALUD. DIRECCION GENERAL DE EPIDEMIOLOGIA: Segunda Encuesta Nacional de Adicciones, México, 1993.

  37. SECRETARIA DE SALUD, SUBSECRETARIA DE PREVENCION Y CONTROL DE ENFERMEDADES, INSTITUTO MEXICANO DE PSIQUIATRIA, DIRECCION GENERAL DE EPIDEMIOLOGIA, CONSEJO NACIONAL CONTRA LAS ADICCIONES: Tercera Encuesta Nacional de Adicciones, ENA, México, 1998.

  38. SECRETARIA DE SALUD, CONSEJO NACIONAL CONTRA LAS ADICCIONES, INSTITUTO NACIONAL DE PSIQUIATRIO, DIRECCION GENERAL DE EPIDEMIOLOGIA, INSTITUTO NACIONAL DE ESTADISTICA GEOGRAFIA E INFOMATICA. Encuesta Nacional de Adicciones. Secretaría de Salud, México, 2002.

  39. SUDAAN: Professional Software for Survey Data Analysis [computer program]. Version 8.0.1. Research Triangle Park, NC: Research Triangle Institute, 2002.

  40. TAPIA-CONYER R, KURI P, CRAVIOTO P y cols.: Situación del consumo del tabaco en México. En: Observatorio Mexicano en Tabaco, Alcohol y otras Drogas 2003. CONADIC, SSA, 63-69, México, 2004.

  41. TAPIA-CONYER R, KURI-MORALES P, CRAVIOTO P y cols.: Sistema de Vigilancia Epidemiológica de las Adicciones (SISVEA). En: Observatorio Mexicano en Tabaco, Alcohol y otras Drogas 2003. CONADIC, SSA, 9-31, México, 2004.

  42. VILLATORO J, MEDINA-MORA ME, CARDIEL H, FLEIZ C y cols.: La situación del consumo de sustancias entre estudiantes de la Ciudad de México: medición otoño 1997. Salud Mental, 22(1):18-30, 1999.

  43. VILLATORO J, MEDINA-MORA ME, CRAVIOTO P, FLEIZ C y cols.: Uso y abuso de drogas en México: Resultados de la Encuesta Nacional de adicciones 2002. En: Observatorio Mexicano en Tabaco, Alcohol y otras Drogas 2003. SSA, 71-84, México, 2004.

  44. VILLATORO J, MEDINA-MORA ME, FLEIZ C, ALCANTAR E y cols.: Trends and evolution of drug use in adolescents of Mexico City: 1989-97. En: NIDA (ed). Community Epidemiology Work Group. NIDA, 393-404. Bethesda, 1998.

  45. VILLATORO J, MEDINA-MORA ME, FLEIZ C, BERMUDEZ P, AMADOR N: Tendencias y factores asociados al consumo de tabaco en los adolescentes de secundaria y bachillerato de la Ciudad de México. En: Valdés- Salgado R, Lazcano-Ponce E, Hernández-Avila M (eds). Primer Informe sobre el Combate al Tabaquismo. México ante el Convenio Marco para el Control del Tabaco. INSP, 65-69, México, 2005.

  46. VILLATORO J, MEDINA-MORA ME, HERNANDEZ M, FLEIZ C y cols.: La Encuesta de Nivel Medio y Medio Superior de la Ciudad de México: noviembre 2003. Prevalencias y evolución del consumo de drogas. Salud Mental, 28(1):38-51, 2005.

  47. VILLATORO J, MEDINA-MORA ME, L OPEZ EK, JUAREZ F Y COLS.: Validación nacional de una escala para evaluar la dependencia y los problemas asociados al consumo de drogas (EPPACD). En: CONADIC (ed). Las Adicciones: Hacia un Enfoque Multidisciplinario, 106-119, CONADIC, Secretaría de Salud, México, 1994.

  48. WOLTER KM: Introduction to Variance Estimation. Springer-Verlag, Nueva York, 1985.

  49. WORLD HEALTH ORGANIZATION (WHO): The World Health Report. Ginebra, 2002.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Salud Mental. 2007;30